Dynamic and simultaneous MR measurement of R1 and R 2* changes during respiratory challenges for the assessment of blood and tissue oxygenation

Magnetic Resonance in Medicine

Volumn 70, Issue 1, 2013, Pages 136-146

  Remmele, Stefanie ^a   Sprinkart, Alois M ^b   Müller, Andreas ^b   Träber, Frank ^b   Von Lehe, Marec ^b   Gieseke, Jürgen ^b,c   Flacke, Sebastian ^b,d   Willinek, Winfried A ^b   Schild, Hans H ^b   Sénégas, Julien ^a   Keupp, Jochen ^a   Mürtz, Petra ^b  

^a PHILIPS RESEARCH LABORATORIES   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c PHILIPS HEALTHCARE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

oxygen enhanced MRI; oxygenation; relaxometry; tumor

Indexed keywords

BLOOD; CEREBROSPINAL FLUID; OXYGENATION; TUMORS;

BLOOD AND TISSUES; INTRACRANIAL TUMORS; PERITUMORAL EDEMA; PHANTOM EXPERIMENT; RELAXOMETRY; RESPONSE AMPLITUDES; SENSITIVITY AND SPECIFICITY; SIMULTANEOUS MEASUREMENT;

OXYGEN SUPPLY;

CARBOGEN;

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; FEMALE; HUMAN; INTRACRANIAL TUMOR; MALE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; RESPIRATORY SYSTEM; SIMULATION; TISSUE OXYGENATION;

EID: 84879420093     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24458     Document Type: Article

References (45)

1. Neeman M, Dafni H,. Structural, functional, and molecular MR imaging of the microvasculature. Annu Rev Biomed Eng 2003; 5: 29-56.
2. Baudelet C, Gallez B,. Current issues in the utility of blood oxygen level dependent MRI for the assessment of modulations in tumor oxygenation. Curr Med Imaging Rev 2005; 1: 229-243.
3. Yetkin FZ, Mendelsohn D,. Hypoxia imaging in brain tumors. Neuroimaging Clin N Am 2002; 12: 537-552.
4. Zhao D, Jiang L, Mason RP,. Measuring changes in tumor oxygenation. Methods Enzymol 2004; 386: 378-418.
5. Punwani S, Ordidge RJ, Cooper CE, Amess P, Clemence M,. MRI measurements of cerebral deoxyhaemoglobin concentration [dHb]-correlation with near infrared spectroscopy (NIRS). NMR Biomed 1998; 11: 281-289.
6. Ogawa S, Lee TM, Nayak AS, Glynn P,. Oxygenation-sensitive contrast in magnetic-resonance image of rodent brain at high magnetic-fields. Magn Reson Med 1990; 14: 68-78.
7. Blockley NP, Jiang L, Gardener AG, Ludman CN, Francis ST, Gowland PA,. Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin. Magn Reson Med 2008; 60: 1313-1320.
8. Young IR, Clarke GJ, Bailes DR, Pennock JM, Doyle FH, Bydder GM,. Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging. J Comput Tomogr 1981; 5: 543-547.
9. Silvennoinen MJ, Kettunen MI, Kauppinen RA,. Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation. Magn Reson Med 2003; 49: 568-571.
10. Zaharchuk G, Martin AJ, Rosenthal G, Manley GT, Dillon WP,. Measurement of cerebrospinal fluid oxygen partial pressure in humans using MRI. Magn Reson Med 2005; 54: 113-121.
11. Matsumoto KI, Bernardo M, Subramanian S, Choyke P, Mitchell J, Krishna M, Lizak M,. Tissue oxygen level dependent magnetic resonance imaging (TOLD-MRI). Free Radic Biol Med 2004; 37: 184-185.
12. Schwarzbauer C, Deichmann R,. Vascular component analysis of hyperoxic and hypercapnic BOLD contrast. NeuroImage 2012; 59: 2401-2412.
13. Karczmar GS, Kuperman VY, River JN, Lewis MZ, Lipton MJ,. Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest Radiol 1994; 29: 161-163.
14. Kuperman VY, River JN, Lewis MZ, Lubich LM, Karczmar GS,. Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn Reson Med 1995; 33: 318-325.
15. Robinson SP, Rodrigues LM, Ojugo AS, McSheehy PM, Howe FA, Griffiths JR,. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer 1997; 75: 1000-1006.
16. Neeman M, Dafni H, Bukhari O, Braun RD, Dewhirst MW,. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med 2001; 45: 887-898.
17. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 2001; 14: 156-163.
18. Baudelet C, Gallez B,. How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? Magn Reson Med 2002; 48: 980-986.
19. Rijpkema M, Schuuring J, Bernsen PL, Bernsen HJ, Kaanders JH, van der Kogel AJ, Heerschap A,. BOLD MRI response to hypercapnic hyperoxia in patients with meningiomas: correlation with Gadolinium-DTPA uptake rate. Magn Reson Imaging 2004; 22: 761-767.
20. Müller A, Remmele S, Wenningmann I, et al. R2* Response of Brain Tumors to Hyperoxic and Hypercapnic Respiratory Challenges at 3 Tesla. In Proceedings of the 17th Annual Meeting of ISMRM, Honolulu, Hawaii, USA, 2009. p. 284.
21. Zhao DW, Jiang L, Hahn EW, Mason RP,. Comparison of H-1 blood oxygen level-dependent (BOLD) and F-19 MRI to investigate tumor oxygenation. Magn Reson Med 2009; 62: 357-364.
22. Christen T, Lemasson B, Pannetier N, Farion R, Remy C, Zaharchuk G, Barbier EL,. Is T2*Enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor. Radiology 2012; 262: 495-502.
23. O'Connor JPB, Jackson A, Buonaccorsi GA, et al. Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times. Magn Reson Med 2007; 58: 490-496.
24. Jones RA, Ries M, Moonen CTW, Grenier N,. Imaging the changes in renal T-1 induced by the inhalation of pure oxygen: a feasibility study. Magn Reson Med 2002; 47: 728-735.
25. Kim KA, Park MS, Kim IS, Kiefer B, Chung WS, Kim MJ, Kim KW,. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation. J Magn Reson Imaging 2012; 36: 405-410.
26. Howe FA, Robinson SP, McIntyre DJ, Stubbs M, Griffiths JR,. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed 2001; 14: 497-506.
27. O'Connor JPB, Naish JH, Jackson A, et al. Comparison of normal tissue R-1 and R-2* modulation by oxygen and carbogen. Magn Reson Med 2009; 61: 75-83.
28. Ding Y, Mason RP, Yuan Q, Hallac RR, McColl RW, Sims RD, Weatherhall PT,. Interleaved T1- and T2*-Weighted Imaging Can Evaluate Dynamic Oxygen Challenge: A Feasibility Study. In Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. p. 1094.
29. Burrel JS, Halliday J, Walker-Samuel S, Waterton JC, Boult J, Jamin Y, Baker LC, Robinson SP,. Investigating dR1 and dR2* as Biomarkers of Tumor Oxygenation. In Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden, 2010. p. 4828.
30. Winter JD, Akens MK, Cheng HLM,. Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia. Phys Med Biol 2011; 56: 1225-1242.
31. Remmele S, Dahnke H, Flacke S, et al. Quantification of the magnetic resonance signal response to dynamic (C)O(2)-enhanced imaging in the brain at 3 T: R(2)* BOLD vs. balanced SSFP. J Magn Reson Imaging 2010; 31: 1300-1310.
32. Treier R, Steingoetter A, Fried M, Schwizer W, Boesiger P,. Optimized and combined T-1 and B-1 mapping technique for fast and accurate T-1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med 2007; 57: 568-576.
33. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM,. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 1997; 7: 266-279.
34. Look D, Locker D,. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970; 41: 250-251.
35. Yarnykh VL,. Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med 2007; 57: 192-200.
36. In den Kleef JJ, Cuppen JJ,. RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med 1987; 5: 513-524.
37. Peebles K, Celi L, McGrattan K, Murrell C, Thomas K, Ainslie PN,. Human cerebrovascular and ventilatory CO2 reactivity to end-tidal, arterial and internal jugular vein PCO2. J Physiol 2007; 584: 347-357.
38. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM,. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005; 54: 507-512.
39. Muller A, Remmele S, Wenningmann I, et al. Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results. Eur Radiol 2011; 21: 786-798.
40. Murtz P, Flacke S, Muller A, et al. Changes in the MR relaxation rate R(2)* induced by respiratory challenges at 3.0 T: a comparison of two quantification methods. NMR Biomed 2010; 23: 1053-1060.
41. Silvennoinen MJ, Kettunen MI, Kauppinen RA,. Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation. Magn Reson Med 2003; 49: 568-571.
42. Falk SJ, Ward R, Bleehen NM,. The influence of carbogen breathing on tumor-tissue oxygenation in man evaluated by computerized Po2 histography. British J Cancer 1992; 66: 919-924.
43. Martin L, Lartigau E, Weeger P, Lambin P, Leridant AM, Lusinchi A, Wibault P, Eschwege F, Luboinski B, Guichard M,. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 1993; 27: 123-130.
44. Blockley NP, Jiang L, Gardener AG, Ludman CN, Francis ST, Gowland PA,. Field strength dependence of R1 and R2* relaxivities of human whole blood to ProHance, Vasovist, and deoxyhemoglobin. Magn Reson Med 2008; 60: 1313-1320.
45. Ashkanian M, Borghammer P, Gjedde A, Ïstergaard L, Vafaee M,. Improvement of brain tissue oxygenation by inhalation of carbogen. Neuroscience 2008; 156: 932-938.